Cite
HARVARD Citation
Tarantelli, C. et al. (n.d.). The novel mTORC1/2 inhibitor PQR620 has in vitro and in vivo activity in lymphomas. European journal of cancer. pp. S38-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tarantelli, C. et al. (n.d.). The novel mTORC1/2 inhibitor PQR620 has in vitro and in vivo activity in lymphomas. European journal of cancer. pp. S38-. [Online].